Glycemic variability in newly diagnosed diabetic cats treated with the glucagon‐like peptide‐1 analogue exenatide extended release

BACKGROUND: Glycemic variability (GV) is an indicator of glycemic control and can be evaluated by calculating the SD of blood glucose measurements. In humans with diabetes mellitus (DM), adding a glucagon‐like peptide‐1 (GLP‐1) analogue to conventional therapy reduces GV. In diabetic cats, the influ...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Vet Intern Med
Main Authors: Krämer, Anna L., Riederer, Angelina, Fracassi, Federico, Boretti, Felicitas S., Sieber‐Ruckstuhl, Nadja S., Lutz, Thomas A., Contiero, Barbara, Zini, Eric, Reusch, Claudia E.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2020
Teme:
SMALL ANIMAL
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7694851/
https://ncbi.nlm.nih.gov/pubmed/33001499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.15915
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki